BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 16421791)

  • 1. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
    White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
    Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients.
    Buchheidt D; Hummel M; Schleiermacher D; Spiess B; Schwerdtfeger R; Cornely OA; Wilhelm S; Reuter S; Kern W; Südhoff T; Mörz H; Hehlmann R
    Br J Haematol; 2004 Apr; 125(2):196-202. PubMed ID: 15059142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.
    Botterel F; Farrugia C; Ichai P; Costa JM; Saliba F; Bretagne S
    Transpl Infect Dis; 2008 Oct; 10(5):333-8. PubMed ID: 18627580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.
    Suarez F; Lortholary O; Buland S; Rubio MT; Ghez D; Mahé V; Quesne G; Poirée S; Buzyn A; Varet B; Berche P; Bougnoux ME
    J Clin Microbiol; 2008 Nov; 46(11):3772-7. PubMed ID: 18845828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
    Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
    Einsele H; Loeffler J
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients.
    Lass-Flörl C; Gunsilius E; Gastl G; Freund M; Dierich MP; Petzer A
    Mycoses; 2005; 48 Suppl 1():12-7. PubMed ID: 15826281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.
    Millon L; Piarroux R; Deconinck E; Bulabois CE; Grenouillet F; Rohrlich P; Costa JM; Bretagne S
    J Clin Microbiol; 2005 Oct; 43(10):5097-101. PubMed ID: 16207969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
    Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
    J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
    Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
    Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
    Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
    Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
    Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
    El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
    Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Foy PC; van Burik JA; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):440-3. PubMed ID: 17287156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M; Malik A; Bhargava R
    Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
    Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
    J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.